Solutions
Two engines, one standard of precision.
We develop clinically validated AI technologies for brain monitoring and neuropsychiatric assessment. NeuroBrowser™ reads the electrical signal, GenMind™ reads voice and cognition. Together they power a new standard in diagnosing and managing brain conditions.
Clinical applications
Transforming care across conditions.
-
Focus, platform
Concussion
Rapid, point-of-care detection of brain slowing and recovery patterns, so return-to-play and return-to-work decisions can be made effectively and safely.
-
Lead program, NeuroBrowser™
Epilepsy
AI-assisted seizure, spike and slowing detection for faster and equally accurate review. Less diagnostic time, more objective analysis.
-
Lead program, GenMind™
Schizophrenia
Quantification of cognitive and negative symptoms through biomarkers, supporting patient monitoring and precision psychiatry at scale.
-
Next program, platform
Bipolar disorder
Serious mental illness monitoring that detects shifts in mood and negative symptom activity across cycles, for more timely and individualized treatment.
Impact that matters
The scale of the problem.
-
1 in 5
people live with a neurological or psychiatric disorder
-
$2 trillion
annual global cost of untreated brain and mental health conditions
-
1,000+
patients already supported by our AI brain analytics
Figures as published on mindsignshealth.com.
Bring these engines into your workflow.
Tell us what you are trying to measure and we will tell you honestly whether we can help yet.
Talk to us